Citation 67204

DILLMAN,RI: CARDELLINA II,JH:. (1991). AROMATIC SECONDARY METABOLITES FROM THE SPONGE TEDANIA IGNIS.. 54(4)

Citation Details

Title	AROMATIC SECONDARY METABOLITES FROM THE SPONGE TEDANIA IGNIS.
Authors	DILLMAN,RI: CARDELLINA II,JH:
Year	1991
Volume	54
Issue	4

Summary

Year: 1991

Journal: Unknown

Organisms and Their Experiments (1)

Tedania ignis (TEDANIIDAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	ACETAMIDE,2-PHENYL:	None
2	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	ACETAMIDE,2-PHENYL:	INACTIVE
3	Not specified	ISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	CARBAZOLE,1-METHYL:	None
4	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBAZOLE,1-METHYL:	ACTIVE
5	Not specified	ISOLATION AND IDENTIFICATION OFPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATA	CARBOLINE,BETA: 1-ACETYL:	None
6	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CARBOLINE,BETA: 1-ACETYL:	ACTIVE
7	Not specified	UV SPECTRUM GIVEN FORISOLATION AND IDENTIFICATION OFMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATA	INDOLE,3-(HYDROXYL-ACETYL):	None
8	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	INDOLE,3-(HYDROXYL-ACETYL):	INACTIVE
9	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BUT-TRANS-3-EN-2-ONE,4-(INDOL-3-YL):	None
10	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BUT-TRANS-3-EN-2-ONE,4-(INDOL-3-YL):	ACTIVE
11	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	PENT-TRANS-3-EN-2-ONE,5-(INDOL-3-YL):	None
12	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	PENT-TRANS-3-EN-2-ONE,5-(INDOL-3-YL):	ACTIVE
13	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	HEPTA-TRANS-3-TRANS-5-DIEN-2-ONE,5-METHYL: 6-(INDOL-3-YL):	None
14	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	HEPTA-TRANS-3-TRANS-5-DIEN-2-ONE,5-METHYL: 6-(INDOL-3-YL):	ACTIVE
15	Not specified	MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	BUT-TRANS-3-EN-2-ONE,4-(2'-3'-4'-TRIMETHYL-PHENYL):	None
16	ANTICRUSTACEAN ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BUT-TRANS-3-EN-2-ONE,4-(2'-3'-4'-TRIMETHYL-PHENYL):	ACTIVE

Show SPARQL Queries (1)